Clinical Trials Browser

Phase 2 × Dendritic Cell Sarcoma, Interdigitating × Lisaftoclax × Clear all

NCT07255963 2025-12-01

Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL

Phase 2 Recruiting

Dendritic Cell Sarcoma, Interdigitating